| Jacob J Brenner Iii, DPT | |
|
167 N Main St, Amherst, WI 54406-9028 | |
| (715) 529-3424 | |
| (715) 251-6236 |
| Full Name | Jacob J Brenner Iii |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 4 Years |
| Location | 167 N Main St, Amherst, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003421355 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Roberts And Associates Physical Therapy Sc | 5890724041 | 8 |
News Archive
New variants of the SARS-CoV-2 virus most likely will necessitate the development of more vaccine options in the years ahead, and a biomedical scientist at Iowa State University believes the "key" to that development lies in the way the virus binds to human cells.
NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).
Researchers at the University of East Anglia and University of Manchester have made an important breakthrough that could lead to ‘kinder' treatments for children with bone cancer, and save lives.
The U.S. Agency for International Development (USAID), NASA, the U.S. Department of State, and NIKE, Inc. have partnered on a unique initiative called LAUNCH. The idea behind LAUNCH is to identify, showcase and support innovative approaches to humanity's sustainability challenges through a series of forums, each focused on a specific sustainability challenge. The second event in the LAUNCH series, LAUNCH: Health, will focus specifically on health issues related to the first 20 years of life.
› Verified 9 days ago
| Provider Name | Roberts & Associates Physical Therapy Sc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1346342839 PECOS PAC ID: 5890724041 Enrollment ID: O20050808000699 |
News Archive
New variants of the SARS-CoV-2 virus most likely will necessitate the development of more vaccine options in the years ahead, and a biomedical scientist at Iowa State University believes the "key" to that development lies in the way the virus binds to human cells.
NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).
Researchers at the University of East Anglia and University of Manchester have made an important breakthrough that could lead to ‘kinder' treatments for children with bone cancer, and save lives.
The U.S. Agency for International Development (USAID), NASA, the U.S. Department of State, and NIKE, Inc. have partnered on a unique initiative called LAUNCH. The idea behind LAUNCH is to identify, showcase and support innovative approaches to humanity's sustainability challenges through a series of forums, each focused on a specific sustainability challenge. The second event in the LAUNCH series, LAUNCH: Health, will focus specifically on health issues related to the first 20 years of life.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacob J Brenner Iii, DPT Po Box 324, Amherst, WI 54406-0324 Ph: (715) 529-3424 | Jacob J Brenner Iii, DPT 167 N Main St, Amherst, WI 54406-9028 Ph: (715) 529-3424 |
News Archive
New variants of the SARS-CoV-2 virus most likely will necessitate the development of more vaccine options in the years ahead, and a biomedical scientist at Iowa State University believes the "key" to that development lies in the way the virus binds to human cells.
NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).
Researchers at the University of East Anglia and University of Manchester have made an important breakthrough that could lead to ‘kinder' treatments for children with bone cancer, and save lives.
The U.S. Agency for International Development (USAID), NASA, the U.S. Department of State, and NIKE, Inc. have partnered on a unique initiative called LAUNCH. The idea behind LAUNCH is to identify, showcase and support innovative approaches to humanity's sustainability challenges through a series of forums, each focused on a specific sustainability challenge. The second event in the LAUNCH series, LAUNCH: Health, will focus specifically on health issues related to the first 20 years of life.
› Verified 9 days ago
Mr. Brett Roberts, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 167 N Main St, Amherst, WI 54406 Phone: 715-529-3487 Fax: 715-251-6236 | |
Nathan Brown, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 167 N Main St, Amherst, WI 54406 Phone: 715-529-3787 Fax: 715-251-6236 | |
Impact Physical Therapy, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 485 Clinton Ct, Amherst, WI 54406 Phone: 715-824-4460 Fax: 715-824-3278 |